We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

98 hedge funds and large institutions have $703M invested in Assembly Biosciences in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 37 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 11

95% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 19

63% more capital invested

Capital invested by funds: $432M → $703M (+$271M)

36% more funds holding

Funds holding: 72 → 98 (+26)

12% more call options, than puts

Call options by funds: $5.62M | Put options by funds: $5.03M

0.56% more ownership

Funds ownership: 5.94% → 6.5% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
98
Holders Change
+26
Holders Change %
+36.11%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
37
Reduced
19
Closed
11
Calls
$5.62M
Puts
$5.03M
Net Calls
+$589K
Net Calls Change
+$2.45M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17M
2
Jennison Associates
Jennison Associates
New York
+$13.1M
3
FCM
Farallon Capital Management
California
+$9.43M
4
Invesco
Invesco
Georgia
+$9.29M
5
EA
Emerald Advisers
Pennsylvania
+$7.23M

Top Sellers

Rank Fund Capital Flow
1
VFA
Valeo Financial Advisors
Indiana
-$4.96M
2
QF
QVT Financial
New York
-$1.86M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.69M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$990K
5
LSC
Lyon Street Capital
California
-$905K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$133M – – –
Jennison Associates
2
Jennison Associates
New York
$95.9M +$13.1M +28,919 +20%
O
3
OrbiMed
New York
$54.2M +$17M +37,500 +60%
ACP
4
Acuta Capital Partners
California
$49.2M +$3.29M +7,259 +9%
BlackRock
5
BlackRock
New York
$48.8M +$6.68M +14,748 +20%
ACA
6
Avoro Capital Advisors
New York
$48.4M +$6.09M +13,448 +18%
Vanguard Group
7
Vanguard Group
Pennsylvania
$34.4M +$3.73M +8,234 +15%
PA
8
Perceptive Advisors
New York
$24.3M +$3.58M +7,900 +21%
RSCM
9
Rock Springs Capital Management
Maryland
$20.4M +$2.26M +5,000 +15%
BBA
10
Baker Bros. Advisors
New York
$14.6M +$2.74M +6,061 +29%
Invesco
11
Invesco
Georgia
$12.5M +$9.29M +20,512 +846%
State Street
12
State Street
Massachusetts
$12.1M +$1.59M +3,505 +19%
FCM
13
Farallon Capital Management
California
$11.3M +$9.43M +20,833 New
Northern Trust
14
Northern Trust
Illinois
$9.96M +$1.1M +2,428 +15%
EA
15
Emerald Advisers
Pennsylvania
$8.67M +$7.23M +15,972 New
Renaissance Technologies
16
Renaissance Technologies
New York
$8.58M +$253K +558 +4%
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$7.92M +$6.6M +14,583 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$7.58M +$1.43M +3,163 +29%
EMFAT
19
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.96M +$5.8M +12,815 New
PC
20
Polar Capital
United Kingdom
$6.8M +$5.67M +12,525 New
Millennium Management
21
Millennium Management
New York
$6.05M +$1.18M +2,600 +30%
JP Morgan Chase
22
JP Morgan Chase
New York
$5.99M -$1.69M -3,743 -25%
LSC
23
Lyon Street Capital
California
$5.68M -$905K -2,000 -16%
Axa
24
Axa
France
$5.35M -$4.98K -11 -0.1%
AC
25
Armistice Capital
New York
$5.07M +$4.22M +9,333 New
1
2 3 4 5

ASMB Hedge Fund Activity: Q4 2017 in Review

98 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2017, worth a combined $703M — up 63% from $432M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASMB positions and 11 closed out — a net gain of 26 holders — while 37 added to existing stakes and 19 trimmed.

The largest buyer was OrbiMed, adding an estimated $17M. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $4.96M sold.

  • 98 institutional investors held Assembly Biosciences (ASMB) as of Q4 2017, up from 72 in Q3 2017.
  • Funds reported $703M of Assembly Biosciences stock for Q4 2017, up 63% quarter-over-quarter.
  • 37 funds opened new Assembly Biosciences positions in Q4 2017 and 11 closed out, a net change of +26 holders.
  • The largest Assembly Biosciences buyer in Q4 2017 was OrbiMed, an estimated $17M added.
  • The largest Assembly Biosciences seller in Q4 2017 was Valeo Financial Advisors, an estimated $4.96M sold.

Based on aggregated 13F filings for Q4 2017.